Selective Serotonin Reuptake Inhibitor (SSRI)

38 marketed 12 in Phase 3 7 in Phase 2

This page covers all Selective Serotonin Reuptake Inhibitor (SSRI) drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Serotonin reuptake transporter, Cytochrome P450 2C19, Melanocortin receptor 5, 5-hydroxytryptamine receptor 2A, Serotonin transporter (SERT).

Targets

Serotonin reuptake transporter · Cytochrome P450 2C19, Melanocortin receptor 5, 5-hydroxytryptamine receptor 2A · Serotonin transporter (SERT) · Dopamine D2 receptor (partial agonist), serotonin 5-HT1A receptor (partial agonist), serotonin transporter (SERT inhibitor) · Serotonin (5-HT) reuptake transporter · Serotonin transporter · Serotonin Transporter (SERT) · serotonin transporter · 5-hydroxytryptamine receptor 1A, D(2) dopamine receptor, Histamine H1 receptor

Marketed (38)

Phase 3 pipeline (12)

Phase 2 pipeline (7)

Patent intelligence